Madrigal Mental Care

Nano particles psychedelics in intranasal delivery for mental health conditions

Health Tech & Life Sciences
Active
Pre-Funding Re'im Founded 2021
Total raised
Stage
Pre-Funding
Founded
2021
Headcount
6
HQ
Re'im
Sector
Health Tech & Life Sciences

About

Madrigal Mental Care is focused on using nanotechnology to accurately deliver psychedelic drugs for the treatment of mental health conditions such as post-traumatic stress disorder (PTSD).

The company's Nanovo intranasal spray is designed to deliver active, nanoencapsulated psychedelic substances directly to the brain for rapid, safe, and efficient uptake.

Madrigal utilizes molecules composed of psychedelic drugs such as psilocybin, ketamine, mescaline, MDMA, and more. By fundamentally changing the coding in the brain, rather than simply treating symptoms, the company is able to offer a transformative solution with minimal side effects.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Materials & SubstancesNanomaterialsBiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsMedical Devices IndustryMedical Products
Business model
B2B

Highlights

1 PatentsVerified

Tags

drug-developmenttreatmentsbiopharmaceuticalnanotechnologybiotechnologydrug-deliverypharmaceuticalsbiodegradablemental-health